Sign Up to Receive Your Personalised Learning Resources
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Arnon Kater, EHA 2023: MURANO substudy analysis: Venetoclax-rituximab in patients with chronic lymphocytic leukaemia
View
Ryan Sullivan, AACR 2023: The STARBOARD phase III trial, encorafenib, binimetinib and pembrolizumab as a combination therapy for BRAF V600 mutant melanoma
View
Temozolomide for Paediatric High-Grade Glioma: Time for a Rethink?
View
Raising awareness around HPV infection, cancer risk and vaccination: PrEvCan | Daniel Kelly
View
Thierry André, ASCO 2023: The SOLISTICE phase III study, trifluridine/tipiracil+bevacizumab in patients with unresectable metastatic colorectal cancer
View
Binod Dhakal, ASCO 2023: The CARTITUDE-4 trial, ciltacabtagene autoleucel for patients with lenalidomide-refractory multiple myeloma
View
Trastuzumab duocarmazine in HER2+ metastatic breast cancer – TULIP trial results: Philippe Aftimos, ESMO 2023
View
Pamela Kearns: Highlights from SIOP Europe 2023
View
Impact of T2D on efficacy of immune checkpoint inhibitors in patients with cancer: Alessio Cortellini
View
Trastuzumab Deruxtecan for the Treatment of HER2-positive Breast Cancer
View